Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Enliven Therapeutics Inc (NASDAQ: ELVN) was $18.42 for the day, down -1.13% from the previous closing price of $18.63. In other words, the price has decreased by -$1.13 from its previous closing price. On the day, 0.51 million shares were traded.
Ratios:
Our analysis of ELVN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 19.99 and its Current Ratio is at 19.99. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on December 13, 2024, initiated with a Buy rating and assigned the stock a target price of $42.
On September 09, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $37.
On June 11, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $32.Robert W. Baird initiated its Outperform rating on June 11, 2024, with a $32 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 07 ’25 when Patel Anish sold 6,667 shares for $18.39 per share. The transaction valued at 122,579 led to the insider holds 309,976 shares of the business.
Patel Anish bought 6,667 shares of ELVN for $131,273 on May 07 ’25. On May 01 ’25, another insider, Lyssikatos Joseph P, who serves as the CHIEF SCIENTIFIC OFFICER of the company, sold 5,030 shares for $20.07 each. As a result, the insider received 100,966 and left with 992,658 shares of the company.
Stock Price History:
Over the past 52 weeks, ELVN has reached a high of $30.03, while it has fallen to a 52-week low of $13.30. The 50-Day Moving Average of the stock is -4.52%, while the 200-Day Moving Average is calculated to be -19.34%.
Shares Statistics:
A total of 48.94M shares are outstanding, with a floating share count of 31.94M. Insiders hold about 35.30% of the company’s shares, while institutions hold 72.83% stake in the company.
